Published in:
01-12-2014 | Erratum
Erratum to: Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours
Authors:
Brigid C. Browne, Alex J. Eustace, Susan Kennedy, Neil A. O’Brien, Kasper Pedersen, Martina S. J. McDermott, Annemarie Larkin, Jo Ballot, Thamir Mahgoub, Francesco Sclafani, Stephen Madden, John Kennedy, Michael J. Duffy, John Crown, Norma O’Donovan
Published in:
Breast Cancer Research and Treatment
|
Issue 3/2014
Login to get access
Excerpt
In the original publication, the authors stated that “high levels of IGF1R and pIGF1R were associated with higher IC50 values for NVP-AEW541, with p values approaching statistical significance (IGF1R: P = 0.053; pIGF1R: P = 0.078)”. This statement should read as “high levels of IGF1R and pIGF1R were associated with lower IC50 values for NVP-AEW541”. Consequently high IGF1R and pIGF1R levels are weakly predictive of sensitivity to NVP-AEW541. These updated data have no significant effect on any of the other statistical correlations listed in the article. …
